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ATTENTION has recently been drawn to
the possible significance within tumours
of cells with the biological characteristics
of macrophages (Russell et al., 1976;
Evans, 1977; Wood & Gollahon, 1977)
including cells bearing receptors for IgG-
coated erythrocytes (Fe receptors) (Mil-
grom et al., 1968; T0nder & Thunold,
1973; Kerbel & Davies, 1974). It has been
suggested that the incidence of these cells
withintumoursmaybeararelationshipboth
to the host's immunological response, and
to the growth, immunogenicity and meta-
static spread of the tumour (Evans, 1972;
Eccles & Alexander, 1974a; Kerbel et al.,
1975; Russell et al., 1976).
The immune response is markedly
affected by agents which influence macro-
phage activity (Halpern et al., 1964;
Fowler & Thomson, 1978) such as C.
parvum (Scott, 1974) and carrageenan
(Thomson, 1978) and which have pro-
found effects on tumour growth (Milas &
Scott, 1978; Thomson & Fowler, 1977;
Keller, 1976). In this preliminary study
we have attempted to determine whether
the influences of C. parvum and car-
rageenan on the growth ofatransplantable
syngeneic tumour are reflected in the pro-
portions of Fc-receptor-positive and
phagocytic cells within the tumour.
Eight to 12-week-old inbred female
C3H He Mg mice derived from stock
obtained from Bantin & Kingman Ltd,
Grimston, Aldborough, Yorkshire, and
weighing 20-25 g were used throughout.
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The tumour used was a syngeneic
adenocarcinoma which arose spontaneous-
ly as a mammary tumour in a virgin
female mouse, and which was obtained
originally from Dr D. Trevan, Imperial
Cancer Research Fund, London. Trans-
plantation was carried out using cell sus-
pensions obtained from 10-day solid sub-
cutaneous tumours, and 106 viable cells
were injected s.c. in the dorsolumbar
region.
A formalin-killed suspension of C.
parvum (Strain Number CN 6134, Batch
BA 3935/A) was a gift from Wellcome
Research Laboratories, Beckenham, Kent,
and contained 7 mg dry wt/ml. Animals
were injected i.p. with 1-4 mg at the same
time as tumour-cell injection. Iota car-
rageenan (Auby Gel x52, Lot 1557) was
prepared and injected as described pre-
viously (Thomson & Fowler, 1977). Mice
received 4 i.p. injections of 1 mg over the
weeks before tumour-cell challenge (Days
-7, -5, -3 and -1).
At 7, 11 and 14 days after cell injection,
tumour tissue was teased apart, and a cell
suspension obtained by gentle homogen-
ization using a loose-fitting rubber pestle.
The cells were washed and allowed to
stand in siliconized glassware for 1 h at
room temperature in Eagle's medium
(MEM, Wellcome) containing 0.1% (w/v)
pancreatic trypsin (Difco). Fragments
were then allowed to settle and the cell
suspension removed, centrifuged and re-
suspended in Eagle's MEM. Cell numbers
Correspondence: Dr A. W. Thomson, Department ofPathology, University Mledlical Btuil(dings, Foresterhill,
Aber(leen, AB9 2ZD.
* Present address: Department ofPathology, The Medical College of St Bartholomew's Hospital, London,.C,. PARVUM, CARRAGEENAN AND SYNGENEIC TUMOURS
were then estimated by haemacytometry.
Carbon-ingesting cells were visualized
by incubating the cells (2 x O6/ml) in a
1: 80 dilution of colloidal carbon (518,
Gunther Wagner, Pelikanwerke, Hanover,
Germany) in MEM supplemented with
10% (v/v) foetal bovine serum (Gibco
Bio-Cult) for 2 h at 37T0 in a humidified
atmosphere of 5% CO2 in air. The inci-
dence of carbon-ingesting cells and cell
viability were then estimated by com-
bined haemacytometry and phase-con-
trast microscopy. Cells bearing Fc recep-
tors were enumerated by rosette forma-
tion, using ox erythrocytes sensitized
with rabbit anti-ox RBC IgG (a gift from
Dr A. E. Dewar, Department of Path-
ology, University of Edinburgh). Tumour
cells (2 x 106) were mixed with red cells at
a ratio of 1: 40, incubated for 10 min at
200C, and then centrifuged at 150 q for
6 min before incubation for 2 h at 4°C.
Two drops of 001% toluidine blue were
added and the cells resuspended by end-
over-end inversion of the tubes before
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FIG. 2. Spleen weights at various times
during tumour growth. Values are mean±
s.e. 0, controls; *, C. parvum-treated;
0, carrageenan-treated.
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40*
estimation of the percentage of rosette-
forming cells.
The significance of differences between
means was estimated using Student's t
test.
Treatment of mice with C. parvum and
iota carrageenan had marked but opposing
effects on tumout growth (Fig. 1). Injec-
tion of C. parvuim impaired growth,
whereas pretreatment with carrageenan
potentiated growth of the tumour. Evi-
dence that both these agents affected
activity of the reticuloendothelial system
was clearly demonstrated by increases in
sDleen weioht ahove those in t1iimcmr- " JJV A%1 %- VX lV V A-A.x fv % V k, UXUtio III Ullil Ul -
-J bearing controls (Fig. 2). Splenomegaly
14 was most pronounced in C. parvum-
ion treated mice, a spectacular increase in
nes weight occurring during the 2 weeks after
11S. injection.
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FIG. 3. Incidence of Fe-receptor-bearing
cells within tumours at various stages of
growth. Values are means ± s.e. 0,controls;
*, C. parvum-treated; 0, carrageenan-
treated.
ing cells represented minor cell popula-
tions within the tumour; their incidence
was related, in untreated animals, to time
after tumour cell injection (Figs. 3 & 4)
and consequently to tumour size. The
former cells were present consistently in
greater proportion than phagocytic cells,
indicating that many of the former were
non-phagocytic.
In C. parvum-treated animals the inci-
dence of Fc-receptor-bearing cells on
Days 11 and 14 were significantly higher
(P<0 05) than in controls, whereas in
carrageenan-treated mice the incidence of
these cells was significantly decreased on
Days 7 and 11 (P<0 05 and P<0-025
respectively). In contrast, the incidence
of carbon-ingesting cells within tumours
was not significantly affected by either
C. parvum or carrageenan.
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FiG. 4.-Carbon-ingesting cells within
tumours at various stages of growth.
Values are means±s.e. 0, controls; *, C.
parvum-treated; *, carrageenan-treated.
Our results clearly demonstrate that
C. parvum and carrageenan exert opposing
effects on growth of a transplantable
tumour within syngeneic hosts, and are
consistent with the reported antagonistic
effect of carrageenan and other anti-
macrophage agents on the anti-tumour
activity of microbial adjuvants (Hopper
et al., 1976; Keller, 1977).
Although splenomegaly is an overt
manifestation of the reticuloendothelial-
stimulating properties of C. parvum, the
significant increase in spleen weight in-
duced by carrageenan is also accompanied
by arelative increase inphagocyte activity
within this organ, with a concomitant
decrease in activity of the liver (Fowler &
Thomson, 1978). However, it is clear from
this study that although increased spleen
weight accompanies the arrest of tumour
growth in the case of C. parvum, the in-
verse correlation exists for carrageenan
treatment. This implies that the systemic
effects of these agents may be of greater
relevance to tumour growth than their
influences on the spleen alone.
The low incidence of Fe-receptor-posi-
tive and phagocyte cells within tumours
in this study is consistent with the scarcity
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of histologically recognizable lympho-
reticular cells within this particular
tumour (Thomson et al., unpublished).
Comparable proportions of cells with
functional macrophage characteristics
have been found within certain other
animal tumours, although considerably
higher incidences have been reported both
in animal and human tumours (Evans,
1972; Eccles & Alexander, 1974a, b;
Russell et al., 1976; Wood & Gollahon,
1977). The decline in the proportion ofFc-
receptor-bearing cells with increased
tumour size observed in the present study
is consistent with work on other tumours
by Szymaniec & James (1976) and Moore
& Moore (1977).
Fc-receptor-bearing cellswithintumours
may constitute a heterogeneous popula-
tion, since a variety of cells, other than
macrophages, including B or T lympho-
cytes, neutrophils, eosinophils and mast
cells may display this characteristic (see
Korn et al., 1978). The relatively higher
incidence of Fc-receptor-positive over
carbon-ingesting cells, which we have
observed, may be explained by the
presence of non-phagocytic monocytes,
such as those described by Haskill et al.
(1976). In the latter study these cells con-
stituted the major effector-cell population,
and it is monocytes rather than mature
macrophages which would be increased by
C. parvum.
It is difficult to reconcile the well-
documented effects of C. parvum and
carrageenan on macrophage activity in
vivo with their failure to influence more
markedly the incidence of cells with
macrophage characteristics within the
tumour, particularly in view of the pro-
nounced effects of these agents on tumour
growth. However, Szymaniec & James
(1976) found that C. parvum occasionally
had an appreciable antitumour effect
without increasing the proportion of Fc-
receptor-positive cells within the tumour.
In contrast, Eccles & Alexander (1974a)
showed that BCG induced a small de-
crease in metastasis which was associated
with a slight increase in tumour macro-
phages. We are aware of no studies other
than the present one on the effect of
carrageenan on the macrophage content
of experimental tumours. Although our
study is based on observations on only one
tumour model, it is clear that the marked
effects of C. parvum and carrageenan on
reticuloendothelial function in vivo are not
necessarily reflected in similarly pro-
nounced alteration in the proportion of
cells with functional macrophage charac-
teristics within solid tumours. Further
studies in progress with C. parvum and
carrageenan, aimed at analysing the initial
interactions between host lymphoreticular
and tumour cells, may help resolve this
apparently paradoxical situation.
We thank the staff of the Animal Department,
University Medical Buildings for management ofthe
animals, the Department of Medical Illustration,
University ofAberdeen for preparation ofthe figures
and Miss Yvonne Gibb for typing the manuscript.
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